J&J neurology news

Johnson & Johnson said in its 2Q12 earnings that it has reached an agreement in principle with the U.S. Department of Justice to settle three civil False Claims Act matters pending in district court. If the agreements are finalized, they will resolve

Read the full 425 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE